Trial intelligence / Profile preview

Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia

NCT03179280Completed

Sponsor
Aristotle University of Thessaloniki
Start
Mar 2011
Primary completion
May 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of insulin aspart in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoint: Post-prandial euglycaemia at 6 hours. Started Mar 2011; status: completed.

02

Drugs

insulin aspart
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT03179280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03179280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call